Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Review of frailty assessment tools in naturally aged mice

This review compares frailty assessment tools used in naturally aged mice and discusses their differences, limits and exploratory future directions. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Naturally aged mice are described as an important platform for studying frailty because functional decline emerges during biological aging rather than through acute injury or artificial manipulation. [1]

  2. Current instruments capture complementary aspects of frailty but differ in dependence on subjective observation, cohort-specific thresholds, testing conditions and validation across sex, strain, laboratory and outcome. [1]

  3. Digital phenotyping, longitudinal trajectories, secondary prognostic models and measures of latent vulnerability may extend current approaches, but these strategies remain exploratory. [1]

The source at a glance

Study type / format
Review (abstract only)
Population / context
Naturally aged mice, as discussed in a review of frailty assessment tools
Summary based on
Study abstract
Original publication
September 2, 2026

Why naturally aged mice are used

Naturally aged mice are described as an important platform for studying frailty, because functional decline emerges during biological aging rather than through acute injury or artificial manipulation. The review examines several tools used in aged mice: the mouse frailty index, the mouse frailty phenotype, a physical function score/vitality score, a mouse social frailty index and a mouse cognitive frailty index.

Supporting source [1]

How the mouse tools differ

The review compares the tools in conceptual foundations, scoring procedures, dimensional coverage, reproducibility, mortality associations, intervention responsiveness and correspondence with clinical models such as the Fried phenotype and the deficit accumulation frailty index. Current instruments capture complementary aspects of frailty but differ in their dependence on subjective observation, cohort-specific thresholds, testing conditions and validation across sex, strain, laboratory and outcome.

Supporting source [1]

Mechanisms and exploratory future directions

The review discusses how biological mechanisms linked to the hallmarks of aging, including inflammaging, immunosenescence, mitochondrial dysfunction, cellular senescence, altered nutrient sensing and impaired stress resilience, may contribute to frailty development. Digital phenotyping, longitudinal trajectories, secondary prognostic models and measures of latent vulnerability may extend current approaches, but these strategies remain exploratory. Alternative weighting systems and a proposed distinction between pre-frailty and subclinical frailty require prospective validation before they can be considered standardized methods.

Supporting source [1]

How to interpret this

This is an abstract of a review; the full text was not reviewed. The abstract reports no sample sizes, study designs or numerical results, and the proposed future directions and distinctions are described as exploratory or requiring prospective validation.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Naturally aged mice provide an important platform
  2. Finding 2 ↑

    Current instruments capture complementary aspects of frailty
  3. Finding 3 ↑

    these strategies remain exploratory

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…